KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Raw Materials (2016 - 2022)

Historic Raw Materials for Charles River Laboratories International (CRL) over the last 13 years, with Q3 2022 value amounting to $35.6 million.

  • Charles River Laboratories International's Raw Materials rose 1353.98% to $35.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was $35.6 million, marking a year-over-year increase of 1353.98%. This contributed to the annual value of $33.1 million for FY2021, which is 1695.45% up from last year.
  • Charles River Laboratories International's Raw Materials amounted to $35.6 million in Q3 2022, which was up 1353.98% from $37.2 million recorded in Q2 2022.
  • Charles River Laboratories International's 5-year Raw Materials high stood at $37.2 million for Q2 2022, and its period low was $20.4 million during Q1 2018.
  • Moreover, its 5-year median value for Raw Materials was $25.4 million (2020), whereas its average is $27.1 million.
  • As far as peak fluctuations go, Charles River Laboratories International's Raw Materials soared by 308.53% in 2020, and later soared by 3007.18% in 2022.
  • Charles River Laboratories International's Raw Materials (Quarter) stood at $22.4 million in 2018, then increased by 9.99% to $24.6 million in 2019, then increased by 15.05% to $28.3 million in 2020, then increased by 16.95% to $33.1 million in 2021, then grew by 7.49% to $35.6 million in 2022.
  • Its last three reported values are $35.6 million in Q3 2022, $37.2 million for Q2 2022, and $34.8 million during Q1 2022.